Pathologic and prognostic impacts of FGFR2 amplification in gastric cancer: a meta-analysis and systemic review

In conclusion, this meta-analysis indicates that FGFR2 amplification is an adverse prognostic factor in patients with GC.

Source: Journal of Cancer - June 13, 2019 Category: Cancer & Oncology Authors: Hyeong Su Kim, Jung Han Kim, Hyun Joo Jang Tags: Research Paper Source Type: research